JP2009518400A5 - - Google Patents

Download PDF

Info

Publication number
JP2009518400A5
JP2009518400A5 JP2008544409A JP2008544409A JP2009518400A5 JP 2009518400 A5 JP2009518400 A5 JP 2009518400A5 JP 2008544409 A JP2008544409 A JP 2008544409A JP 2008544409 A JP2008544409 A JP 2008544409A JP 2009518400 A5 JP2009518400 A5 JP 2009518400A5
Authority
JP
Japan
Prior art keywords
composition
composition according
macrocyclic lactone
benzimidazole
moxidectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008544409A
Other languages
English (en)
Japanese (ja)
Other versions
JP5342239B2 (ja
JP2009518400A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/046197 external-priority patent/WO2007067470A2/en
Publication of JP2009518400A publication Critical patent/JP2009518400A/ja
Publication of JP2009518400A5 publication Critical patent/JP2009518400A5/ja
Application granted granted Critical
Publication of JP5342239B2 publication Critical patent/JP5342239B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008544409A 2005-12-06 2006-12-04 ベンジイミダゾール非水性組成物 Expired - Fee Related JP5342239B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74272405P 2005-12-06 2005-12-06
US60/742,724 2005-12-06
PCT/US2006/046197 WO2007067470A2 (en) 2005-12-06 2006-12-04 Benzimidazole non-aqueous compositions

Publications (3)

Publication Number Publication Date
JP2009518400A JP2009518400A (ja) 2009-05-07
JP2009518400A5 true JP2009518400A5 (enExample) 2013-07-04
JP5342239B2 JP5342239B2 (ja) 2013-11-13

Family

ID=37903547

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544409A Expired - Fee Related JP5342239B2 (ja) 2005-12-06 2006-12-04 ベンジイミダゾール非水性組成物

Country Status (15)

Country Link
US (1) US7687471B2 (enExample)
EP (1) EP1957040B1 (enExample)
JP (1) JP5342239B2 (enExample)
KR (1) KR20080073700A (enExample)
AR (1) AR057219A1 (enExample)
AU (1) AU2006322120B2 (enExample)
BR (1) BRPI0619620B1 (enExample)
CA (1) CA2630458C (enExample)
DK (1) DK1957040T3 (enExample)
ES (1) ES2527120T3 (enExample)
NZ (1) NZ567991A (enExample)
PT (1) PT1957040E (enExample)
TW (1) TWI433691B (enExample)
WO (1) WO2007067470A2 (enExample)
ZA (1) ZA200804915B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007144362A1 (en) 2006-06-14 2007-12-21 Intervet International B.V. A suspension comprising benzimidazole carbamate and a polysorbate
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
PT2331068T (pt) * 2008-10-08 2017-03-13 Zoetis Services Llc Composições anti-helmínticas de benzimidazol
WO2010126857A1 (en) * 2009-04-28 2010-11-04 Wyeth Llc Parasiticidal combinations of macrocyclic lactones and polyether antibiotics
US9808529B2 (en) 2012-05-18 2017-11-07 Luoda Pharma Pty Ltd Liquid formulation
BR102013031277B1 (pt) * 2013-12-05 2018-10-02 Ouro Fino Participacoes E Empreendimentos S A processo para preparar uma suspensão anti-helmíntica e suspensão anti-helmíntica injetável
CN112006981B (zh) * 2020-07-30 2023-01-10 瑞普(天津)生物药业有限公司 一种长效复方驱虫药物液体制剂及其制备方法与应用
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형
BR102020021181A2 (pt) * 2020-10-16 2022-04-26 Ipanema Industria De Produtos Veterinarios Ltda Microssuspensão contra parasitas e método para sua obtenção
CN114304161B (zh) * 2021-11-25 2024-08-09 兰州大学 三氯苯达唑在防治农业病原菌中的用途
WO2025221973A1 (en) * 2024-04-18 2025-10-23 Jjr&D, Llc Topical benzimidazole formulations and methods for use in treating inflammatory dermatoses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840324A (en) * 1993-05-26 1998-11-24 Commonwealth Scientific And Industrial Organisation Antiparasitic compositions
FR2755824B1 (fr) * 1996-11-19 1999-01-08 Virbac Sa Formulation galenique des benzimidazoles a usage topique, son procede de preparation et ses utilisations
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
ATE313952T1 (de) * 1999-06-04 2006-01-15 Nufarm Ltd Stabile biozidale zusammensetzung
NZ515772A (en) * 1999-06-04 2002-12-20 Nufarm Ltd Pesticidal emulsion composition containing levamisole in the aqueous phase and an anthelmintic in the organic phase
CN1435176A (zh) 2002-01-29 2003-08-13 王玉万 以表面活性剂为基础的含三氯苯哒唑的新制剂
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
NZ585223A (en) * 2004-02-03 2011-01-28 Wyeth Llc Anthelmintic composition comprising milbemycin, triclabendazole and a non-surfactant rheology modifier

Similar Documents

Publication Publication Date Title
ES2743673T3 (es) Composiciones parasiticidas orales veterinarias que comprenden agentes activos de acción sistémica, procedimientos y usos de las mismas
ES2423505T3 (es) Combinación antihelmíntica
JP2011105765A (ja) 表面殺寄生生物処方物および処置方法
AR081754A1 (es) Composiciones parasiticidas que comprenden multiples agentes activos, metodos y usos de las mismas
HRP20211042T1 (hr) Dugodjelujuće injektibilne formulacije koje sadrže antiparazitske izoksazolinske spojeve i njihove uporabe
JP2010535231A (ja) 内部寄生虫駆除局所組成物
AR078860A1 (es) Asociaciones farmaceuticas, composiciones farmaceuticas, medicamento y metodo para el tratamiento de animales
AR079409A1 (es) Preparaciones antihelminticas granuladas y sistemas de suninistros
CN106132409A (zh) 稳定的兽用驱虫制剂
JP5342239B2 (ja) ベンジイミダゾール非水性組成物
ES2617672T3 (es) Composiciones antihelmínticas de bencimidazol
WO2004069242A1 (en) Anthelmintic composition
AU2003275779B2 (en) Topical parasiticide formulations and methods of treatment
KR101233488B1 (ko) 구충 제형
AU2005101039A4 (en) Stable Parasiticide Composition
AU2012200544C1 (en) Anthelmintic composition
ES2882976T3 (es) Formulación para administración tópica